Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Biofly AB
AB
Active
Org 5593471161
Katrinebergsvägen 2, 117 61
Stockholm
General medical practice activities
· NACE 8621
Est. 2021
1 employees
Watchlist
Share
Sweden
/
Companies
/
General medical practice activities
/
Biofly AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2022
2023
2024
Revenue
1 154
419
308
Staff expenses
—
—
—
EBITDA
731
−136
118
Depreciation & amort.
−0
−39
−105
EBIT
731
−175
13
Net financials
−366
—
—
Profit before tax
548
8
13
Tax
−113
−2
−3
Net profit
435
6
10
Balance sheet
SEK thousands
Item
2022
2023
2024
Total assets
1 050
597
416
Equity
460
279
288
Long-term debt
0
0
0
Short-term debt
407
319
127
Total debt
407
319
127
Financial ratios
5-year trend
EBITDA margin
38.3%
This company
15.8%
Market median
+142% vs market
2022
2024
Equity ratio
69.2%
This company
38.2%
Market median
+81% vs market
2022
2024
Return on equity
3.5%
This company
18.4%
Market median
-81% vs market
2022
2024
Net profit margin
3.2%
This company
8.1%
Market median
-60% vs market
2022
2024
Asset turnover
0.74×
This company
1.12×
Market median
-34% vs market
2022
2024
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-11-01 – 2022-12-31
View
PDF
More on Biofly AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
